Dapagliflozin
- Product NDC
- 50090-7971
- 11-digit product format
- 500907971
- Labeler code
- 50090
- Product ID
- 50090-7971_a927d507-82ba-4f9b-bb5a-6ee0f6cba923
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapagliflozin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA211468
- Marketing category
- ANDA
- Marketing start
- 2026-04-06
- Substance
- DAPAGLIFLOZIN
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 1ULL0QJ8UC | DAPAGLIFLOZIN | 461432-26-8 | DAPAGLIFLOZIN |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7971-0 | 50090797100 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-7971-0) | 2026-05-14 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Dapagliflozin | A-S Medication Solutions | 2026-05-18 | Human Prescription Drug Label | 1 |